Mucinex D

Sneezing, Tracheitis, Emphysema + 43 more

Treatment

5 FDA approvals

20 Active Studies for Mucinex D

What is Mucinex D

Guaifenesin

The Generic name of this drug

Treatment Summary

Guaifenesin is an expectorant medication used to reduce chest congestion. It was approved by the FDA in 1952 and is available as both a prescription and over-the-counter product. In 2008, the FDA asked manufacturers to stop using guaifenesin in children under the age of 4 due to safety concerns. Recent research has also suggested that guaifenesin may have anticonvulsant and muscle relaxant effects.

Goyescas 7 Syrups Original Cough and Cold

is the brand name

Mucinex D Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Goyescas 7 Syrups Original Cough and Cold

Guaifenesin

1958

497

Approved as Treatment by the FDA

Guaifenesin, also called Goyescas 7 Syrups Original Cough and Cold, is approved by the FDA for 5 uses which include Productive cough and induction of Productive cough .

Productive cough

induction of Productive cough

chest congestion

Phlegm

Coughing

Effectiveness

How Mucinex D Affects Patients

Guaifenesin is an expectorant that works by thinning out mucus and phlegm, which makes it easier for the body to cough it up. It also increases the flow of fluid in the stomach, which helps the cilia in the airways do their job of clearing away mucus and phlegm. In other words, guaifenesin makes coughing more productive and less frequent.

How Mucinex D works in the body

Guaifenesin is believed to help clear out mucus that is stuck in the airways. It does this by increasing mucus production and irritating the stomach, which causes coughing. Coughing helps to clear out the mucus. Research also suggests that guaifenesin can act as a muscle relaxant and anticonvulsant, likely by blocking certain nerve receptors.

When to interrupt dosage

The measure of Mucinex D is contingent upon the diagnosed condition, for example, Pollen Allergy, Drug Allergy and Allergic Reaction. The dose shifts as indicated by the approach of delivery represented in the table below.

Condition

Dosage

Administration

Phlegm

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Common Cold

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Whooping Cough

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

House dust allergy

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Hives

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Acute Bronchitis

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Exanthema

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Bronchial Spasm

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Rhinitis, Allergic

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Productive cough

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Coughing

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Rhinorrhea

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Fever

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Influenza

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Chronic Obstructive Pulmonary Disease

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Tobacco Use

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Pharyngitis

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Bronchitis, Chronic

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Food Hypersensitivity

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Asthma

20.0 mg/mL, , 100.0 mg/mL, 40.0 mg/mL, 200.0 mg/mL, 400.0 mg, 50.0 mg/mL, 200.0 mg, 600.0 mg, 225.0 mg/mL, 400.0 mg/mL, 300.0 mg/mL, 350.0 mg/mL, 100.0 mg, 10.0 mg/mL, 150.0 mg, 120.0 mg/mL, 395.0 mg, 388.0 mg/mL, 187.0 mg/mL, 388.0 mg, 25.0 mg/mL, 175.0 mg/mL, 60.0 mg/mL, 70.0 mg/mL, 90.0 mg/mL, 150.0 mg/mL, 75.0 mg/mL, 8.33 mg/mL, 380.0 mg, 390.0 mg, 125.0 mg/mL, 88.0 mg/mL, 1200.0 mg, 30.0 mg/mL, 375.0 mg, 35.0 mg, 2.0 mg/mL, 240.0 mg, 120.0 mg, 50.0 mg, 24.99 mg, 385.0 mg, 198.0 mg, 190.0 mg, 835.0 mg, 800.0 mg, 350.0 mg, 550.0 mg, 288.0 mg, 775.0 mg, 580.0 mg, 180.0 mg, 78.0 mg/mL, 780.0 mg, 1000.0 mg, 575.0 mg, 315.0 mg, 1100.0 mg, 650.0 mg, 15.0 mg/mL, 275.0 mg, 300.0 mg, 360.0 mg, 211.0 mg/mL, 35.0 mg/mL, 80.0 mg/mL, 4.2 mg/mL, 0.2 mg, 41.6 mg, 0.007 mg/mg, 0.21 mg/mg, 20.84 mg, 39.6 mg/mL, 0.4 mg/mg, 25.0 mg, 4.0 mg/mL, 37.5 mg/mL, 5.0 mg/mL, 22.1 mg/mL, 10000.0 mg/mL

, Liquid, Liquid - Oral, Solution, Oral, Solution - Oral, Powder, for solution, Powder, for solution - Oral, Syrup, Syrup - Oral, Tablet, coated, Tablet, film coated - Oral, Suspension, Suspension - Oral, Tablet, extended release, Tablet, film coated, Tablet, extended release - Oral, Tablet, coated - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Kit, Tablet, Tablet - Oral, Solution / drops, Capsule, coated - Oral, Capsule, coated, Capsule, Capsule - Oral, Suspension / drops, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Solution / drops - Oral, Suspension / drops - Oral, Solution / drops - Nasal, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Granule - Oral, Granule, Elixir - Oral, Nasal, Elixir, Suppository - Rectal, Suppository, Kit; Tablet, Kit; Tablet - Oral, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Rectal, Capsule; Kit - Oral, Capsule; Kit, Kit - Oral, Tablet, multilayer, Tablet, multilayer - Oral, Gel - Oral, Gel, Nasal; Oral, Powder, Powder - Oral, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated - Oral; Topical, Oral; Topical, Cream; Kit; Liquid; Ointment; Tablet; Tablet, chewable; Tablet, film coated

Warnings

Mucinex D has one contraindication and should not be administered when encountering any of the conditions enumerated in the following table.

Mucinex D Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Guaifenesin may interact with Pulse Frequency

Common Mucinex D Drug Interactions

Drug Name

Risk Level

Description

Mucinex D Toxicity & Overdose Risk

Vomiting and nausea are common side effects of an overdose of guaifenesin. There have not been any studies on pregnant women, but a study on 197 mother-child pairs found an increased occurrence of inguinal hernias in the newborns. Guaifenesin is also excreted in breast milk, so caution should be taken when administering it to nursing mothers. An extremely high dose of guaifenesin has been found to be toxic to rats, with an LD50 value of 1510mg/kg.

Mucinex D Novel Uses: Which Conditions Have a Clinical Trial Featuring Mucinex D?

Presently, 309 active studies are assessing the use of Mucinex D in alleviating symptoms of Rash, Sore Throat and Chronic Coughing.

Condition

Clinical Trials

Trial Phases

Tracheitis

0 Actively Recruiting

Fever

2 Actively Recruiting

Not Applicable, Phase 4

Asthma

92 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3

Chronic Obstructive Pulmonary Disease

76 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Coughing

0 Actively Recruiting

chills occurring with fever

0 Actively Recruiting

Influenza

29 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3

Tobacco Use

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Pain

0 Actively Recruiting

Coughing

0 Actively Recruiting

excess mucus or phlegm

0 Actively Recruiting

Coughing

0 Actively Recruiting

Laryngitis

0 Actively Recruiting

Whooping Cough

0 Actively Recruiting

Exanthema

0 Actively Recruiting

Coughing

0 Actively Recruiting

Emphysema

4 Actively Recruiting

Phase 2, Not Applicable

Acute Bronchitis

1 Actively Recruiting

Not Applicable

Mucinex D Reviews: What are patients saying about Mucinex D?

5

Patient Review

1/22/2014

Mucinex D for Inflammation of the Nose due to an Allergy

I've had allergies for years and this is the first medication that has actually helped me. It's great to be able to breathe normally again. I only take it once a day, but I worry about potential side effects from long-term use.

5

Patient Review

4/13/2017

Mucinex D for Stuffy Nose

This is the only medication that has worked for me when it comes to clearing up nasal passages and getting rid of phlegm. It's a miracle worker! I've never had any side effects from using it, but I know someone who can't use it because she's intolerant to pseudoephedrine. If you're having problems with this product, that might be why.

5

Patient Review

10/10/2020

Mucinex D for Inflammation of the Nose due to an Allergy

Although this drug did help with my congestion, the side effects were really tough to deal with. I would recommend not taking it before bed because it made me drowsy during the day but kept me up at night.

5

Patient Review

2/11/2014

Mucinex D for Inflammation of the Nose due to an Allergy

This, in conjunction with my other allergy medications, has been extremely effective.

5

Patient Review

9/13/2021

Mucinex D for Inflammation of the Nose due to an Allergy

I am thankful that I found this product, which works 100% of the time for me. I have allergies and often suffer from earaches, sinus issues, cough, and bronchitis. This product has been a lifesaver.

5

Patient Review

1/24/2013

Mucinex D for Inflammation of the Nose due to an Allergy

4.7

Patient Review

5/21/2015

Mucinex D for Inflammation of the Nose

This medication has been amazing for me after everything I've gone through. It's the only thing that really stops the pressure in my face. The drowsiness it causes during the day is a small price to pay, in my opinion. Make sure to drink lots of water and use NeilMed Sinus Rinse when you take this medication.

3.3

Patient Review

1/3/2016

Mucinex D for Cough

I followed the advice of a pharmacist and tried this product. I was disappointed overall. I took the 12 hour extended release version and it worked well for the first 6 hours; however, right at the 6th hour my cough kicked back in. Now I'm stuck suffering until the 12 hours is up.

3.3

Patient Review

4/7/2016

Mucinex D for Cold Symptoms

Overall, this medicine did the job in terms of clearing my sinuses. However, the foul smell that came along with it was unbearable. I would wake up multiple times throughout the night just because of how pungent it was. Thankfully, I wasn't alone in this experience and others could attest to the fact that it's not just me being sensitive.

3

Patient Review

8/17/2013

Mucinex D for Inflammation of the Nose due to an Allergy

Is it okay to take mucinex-d with benadryl?

2.3

Patient Review

1/3/2015

Mucinex D for Cold Symptoms

Unfortunately, I haven't personally found this to be effective. After taking two doses, I experienced drowsiness and a loss of appetite--but no change in my symptoms.

2

Patient Review

10/31/2013

Mucinex D for Cough

I found Mucinex didn't really help with my coughing. I'm still waiting for it to take effect, and it's been over an hour now. Not sure if I would recommend this product.

1.7

Patient Review

2/12/2015

Mucinex D for Cold Symptoms

Save your money--this product did nothing for me. I was already sick when I bought it and it failed to deliver on its promises.

1.7

Patient Review

12/1/2020

Mucinex D for Cold Symptoms

I used this for a full day and saw zero results. If anything, I felt more congested than before. Do not bother buying this medication; it's a waste of money.

1.3

Patient Review

11/6/2014

Mucinex D for Inflammation of the Nose

I only experienced a few hours of relief before developing a headache. I'm not happy with this product and would like my money back.

1

Patient Review

2/24/2019

Mucinex D for Stuffy Nose

Mucinex D didn't work for me at all. I could tell no difference after taking it for three days, and it was quite expensive too.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about mucinex d

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Mucinex D put you to sleep?

"Mucinex D is a combination medication that contains guaifenesin and pseudoephedrine. These two substances work together to help relieve a stuffy nose and a cough that is accompanied by mucus. However, Mucinex D may cause insomnia and prevent users from getting a good night's sleep."

Answered by AI

When should you not take Mucinex D?

"This medicine is not recommended for use if you have previously had an allergic reaction to any decongestant or cough medicine, or if you have taken an MAO inhibitor such as Nardil, Marplan, Eldepryl, or Parnate within the past 14 days."

Answered by AI

What is Mucinex D for?

"This medication is a combination of drugs that are used to temporarily treat cough and nasal congestion. The drugs work by clearing the respiratory tract and facilitating easier breathing. The medication is effective against infections, allergies, and other breathing illnesses."

Answered by AI

What is the difference between Mucinex DM and D?

"Mucinex D is an expectorant/nasal decongestant combination, while Mucinex DM is an expectorant/cough suppressant combination."

Answered by AI

Clinical Trials for Mucinex D

Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Have you considered Mucinex D clinical trials?

We made a collection of clinical trials featuring Mucinex D, we think they might fit your search criteria.
Go to Trials
Image of Stanford University in Stanford, United States.

MoblO2 for Chronic Lung Diseases

18+
All Sexes
Stanford, CA

Many patients with chronic lung disease (e.g., chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD)) require supplemental oxygen (O2) at some point during their disease course. Practitioners prescribe O2 to patients with chronic lung disease in hopes of the following: 1) that it will limit desaturation events and combat breathlessness, thus preventing the frustratingly slow pace and numerous rest breaks patients are forced to adopt while doing even simple tasks; 2) that it will allow patients to be more active physically (perhaps increase their ability to exercise) and socially (perhaps leave the home more often); 3) that it will stave off putative complications of hypoxemia (e.g., cognitive dysfunction, pulmonary hypertension) and 4) that it will improve health-related quality of life (HRQL). However, despite the rationale for O2, and prescribers' good intentions, patients generally view O2 with frustration and fear - it threatens their HRQL, which is already impaired by having a condition that imposes itself on every aspect of their lives. Nasal cannulas and delivery devices call unwanted attention to patients when they are out in public. O2 users feel stigmatized and are often viewed as "smokers who get what they deserve, even if they never smoked a day in their lives" - or as disabled, sick or even infectious. O2 steals patients' independence, forcing them to plan their lives around it. The anxiety that patients and their caregivers experience around running out of oxygen, or not getting enough, immobilizes them and restricts participation in activities outside of the home. O2 disrupts the home environment, adding stress, and creating a burden for patients' caregiver-loved-ones who are often saddled with the responsibility of ensuring adequate equipment and supply of O2, and O2 is a constant reminder to patients they are living with a condition that could shorten their lives. O2 delivery equipment is typically heavy, unwieldy and intimidating. Different recommendations (e.g., insurance companies use 88% as a cut-off for SpO2, while many practitioners focus on 90%) make it confusing for patients, which almost certainly affects adherence. O2-requiringpatients are starving for things that can make their lives easier. An auto-adjusting O2 delivery device - one that automatically delivers the correct amount of O2 to maintain blood oxygen at desired, pre-set levels - would alleviate the need for patients to constantly (incessantly for many) monitor their peripheral oxygen saturation (SpO2) and adjust O2flow to meet the demands as exertion levels vary . The MoblO2 device is a battery-operated, light-weight, closed-loop O2 delivery device that houses a regulator (which attaches to compressed gas O2 tanks) and adjusts O2 flow to meet a pre-set blood oxygen level. A pulse oximeter is worn on the ear and transmits via Bluetooth to the device, which adjusts an internal valve to control flow on a second-to-second basis. The user sets the dial to the highest flow of O2 needed to meet the demands of activities they might perform (up to 15 liters per minute), and the device adjusts flow, up to the pre-set level to maintain SpO2 at a preset level (e.g., \> 90%). To conserve O2 supply in the tank - and to avoid over-oxygenation (which could be problematic for a small percentage of patients with the most severe COPD) - the MoblO2 begins to limit O2 flow at a SpO2 of 93%. The device can be manually over-ridden by the user, and should the battery run out - or the device fail for some unforeseen reason - the default position is valve open, so the users receive whatever flow of oxygen has been set on the dial. Given the substantial burdens of O2 on patients and their families, the hassles patients describe with having to monitor their SpO2 and repeatedly adjust the flow of O2 to meet their needs, patients and experts around the world have called for improvements in O2 delivery equipment. The MoblO2 is just such a remarkable improvement and a giant step forward in helping to ease the burdens of O2 on patients who require it. The purpose of this study is to investigate the effects of the MoblO2 O2 delivery device on a range of outcomes, including physical activity, amount (liters) O2 use; maintenance of adequate SpO2 levels; patient reported outcomes including symptoms, HRQL and satisfaction with the MoblO2 O2 device.

Waitlist Available
Has No Placebo

Stanford University

Jeff Swigris, DO, MS

Minnesota Health Solutions

Have you considered Mucinex D clinical trials?

We made a collection of clinical trials featuring Mucinex D, we think they might fit your search criteria.
Go to Trials
Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.

Phase 2
Waitlist Available

National Institutes of Health Clinical Center (+1 Sites)

Luca T Giurgea, M.D.

Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN

This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?

Phase 2
Recruiting

Vanderbilt University Medical Center

Natahsa Halasa, MD, MPH

Have you considered Mucinex D clinical trials?

We made a collection of clinical trials featuring Mucinex D, we think they might fit your search criteria.
Go to Trials